METHODS OF TARGETED TREATMENT OF FRONTOTEMPORAL LOBAR DEGENERATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140179678A1
SERIAL NO

14007572

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides targeted treatment to subjects suffering from Frontotemporal lobar degeneration through use of FTLD targeted agents, as described in the present invention. In particular, the FTLD targeted agents provided herein demonstrate high brain penetration, which decreases risk issues associated with peripheral administration. Furthermore, the FTLD targeted agents of the present invention, when administered to a subject selected for treatment based on the results of a FTLD diagnostic assay, offer targeted treatment of FTLD.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FORUM PHARMACEUTICALS INC500 ARSENAL STREET WATERTOWN MA 02472

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blain, Jean-Francois Jamaica Plain, US 1 1
Koenig, Gerhard Newton, US 39 225
Patzke, Holger Belmont, US 20 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation